Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : THE SLIGHTLY MODERATED BOXING RING -- Ignore unavailable to you. Want to Upgrade?

To: Patricia Trinchero who wrote (4924)	3/26/2002 3:48:21 PM
From: Lazarus_Long	Respond to of 21057

The approval process in Europe is less stringent and less costly So that's why Europe always has drugs available before the US! My wife has bad asthma and new drugs for it are always available in Europe before they are here. It would be interesting to see their drug-related mortality statistics as compared to the US. The thalidomide disaster is well known, but that was 40 years ago. but the big money is in the US marketplace. Yup. Most companies charge less for their drugs in other countries Yup. we end up subsidizing the rest of the world. Yup. We pay the development and approval costs, which are in the billions. Then other countries get the benfit of that. Many countries don't really have the equivalent of an FDA. They rely on US approval. We have more money so we pay more money Yup. There is talk of controlling drug prices in the US. Which juswt could be killing the goose that lays those treatments and cures. it's unfortunate but true. Yup. I think there is starting to be alot of discussion about people ordering their drugs online from Canada. Some of the drugs are 1/2 price and the generic drugs are 1/4!!!!! That's pretty amazing. Yup. Tell it to marcos. He keeps whining about how we're exploiting the Canadians. Subject 51596